TITLE

Hydromorphone Neuroexcitation

AUTHOR(S)
Thwaites, Daniel; McCann, Shawn; Broderick, Peter
PUB. DATE
August 2004
SOURCE
Journal of Palliative Medicine;Aug2004, Vol. 7 Issue 4, p545
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Continuous parenteral hydromorphone is used to treat pain in palliative care. Case reports have suggested that neuroexcitatory symptoms, such as agitation, myoclonic activity, and even seizures may occur during administration. However, little information exists on the incidence of these side effects or their relationship to the dose or duration of parenteral hydromorphone. A retrospective chart review was performed on 48 terminally ill hospice patients who received continuous parenteral hydromorphone for pain control. Chart reviews were conducted searching for three neuroexcitatory symptoms: agitation, myoclonus, and seizures; the incidence and relationship of these symptoms were statistically compared to the maximal dose and number of days on continuous parenteral hydromorphone. We found that agitation, myoclonus, and seizures were not associated with the patients gender, age, or diagnosis but found that agitation was associated (p < 0.01) in patients with known metastatic disease. Agitation, myoclonus, and seizures were independently associated with the maximal dose (p < 0.05, p 0.001, and p < 0.05) and with the duration (p < 0.01, p < 0.05, and p < 0.01) of continuous parenteral hydromorphone A possible mechanism for these findings is hydromorphone-3-glucoronide, a metabolic product of hydromorphone, which has been implicated in neuroexcitatory symptoms in laboratory investigations.
ACCESSION #
14327415

 

Related Articles

  • Neuropathic Pain in Cancer Patients—Prevalence and Management in a Tertiary Care Anesthesia-Run Referral Clinic Based in Urban India. Bhatnagar, Sushma; Mishra, Seema; Roshni, S.; Gogia, Vikas; Khanna, Sandeep // Journal of Palliative Medicine;Jul2010, Vol. 13 Issue 7, p819 

    Background: Cancer pain is often intractable and has a considerable impact on the quality of life. Nociceptive pain is easily recognized and managed using conventional analgesics. The neuropathic component makes cancer pain difficult to manage. The epidemiology of neuropathic pain in cancer...

  • One size doesn't fit all. Crespi-Lofton, Judy // Pharmacy Today;Aug2004, Vol. 10 Issue 8, p10 

    The wide array of analgesic medications available today make good pain management a possibility for most patients. However, a treatment regimen and dosage that works well for one patient may not be as effective for another patient with a similar diagnosis and pain rating or may cause intolerable...

  • Letters to the Editor. Woodall, Hunter E.; Sasson, Menahem; Shvartsman, Pesach // American Family Physician;7/1/2002, Vol. 66 Issue 1, p28 

    Discusses alternatives to rehydration in palliative care settings. Information on parenteral medications during hypodermoclysis; Application of hypodermoclysis in three classes of patients; Administration of drugs via hypodermoclysis without the use of a pump.

  • Freedom from pain goes a long way to a "good death". Riley, Julia // BMJ: British Medical Journal (International Edition);7/26/2003, Vol. 327 Issue 7408, p235 

    Offers observations on the palliative care received by a young mother. Attendance by her family at a bereavement counselling session; Quality of her care; Use of analgesics to relieve pain of dying.

  • A Comparative Study Of Ketamine And Tramadol As Additives To Plain Bupivacaine In Caudal Anaesthesia In Children. Somasundaran, S.; Garasia, Madhu // Internet Journal of Anesthesiology;2008, Vol. 17 Issue 2, p8 

    Background: Studies examining the benefits of additives to bupivacaine in caudal anaesthesia have produced mixed results. Although the mechanism of action of these analgesics remains unclear, ketamine and tramadol have been used successfully in caudal block for prolonged postoperative pain...

  • Parenteral antibiotics in a palliative care unit: prospective analysis of current practice. Clayton, Josephine; Fardell, Belinda; Hutton-Potts, Jane; Webb, David; Chye, Richard // Palliative Medicine;Jan2003, Vol. 17 Issue 1, p44 

    All patients receiving parenteral antibiotics in a palliative care unit were prospectively monitored over a 13-month period. Of 913 consecutive admissions, 41 patients received 43 courses of parenteral antibiotics. On 27 of 43 occasions, the use of parenteral antibiotics was considered helpful...

  • Hydromorphone Rectal.  // AHFS Consumer Medication Information;Oct2019, p1 

    Hydromorphone suppositories are used to relieve moderate to severe pain. Hydromorphone is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain.

  • Intrathecal Analgesia and Palliative Care: A Case Study. Salins, Naveen S.; Crawford, Gregory B. // Indian Journal of Palliative Care;Jan2010, Vol. 16 Issue 1, p44 

    Intrathecal analgesia is an interventional form of pain relief with definite advantages and multiple complications. Administration of intrathecal analgesia needs a good resource setting and expertise. Early complications of intrathecal analgesia can be very distressing and managing these...

  • Prostate cancer pain management: EAU guidelines on pain management. Bader, Pia; Echtle, Dieter; Fonteyne, Valerie; Livadas, Kostas; Meerleer, Gert; Paez Borda, Alvaro; Papaioannou, Eleni; Vranken, Jan // World Journal of Urology;Oct2012, Vol. 30 Issue 5, p677 

    Context: The first publication of the European Association of Urology (EAU) guidelines on Pain Management in Urology dates back to 2003. Since then, these guidelines have been revised several times with the most recent update achieved in 2010. Objective: Given the scope of the full text...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics